Canada Artificial Intelligence in Healthcare Market Size & Report 2025-2033

Market Overview 2025-2033

The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033, exhibiting a growth rate (CAGR) of 36.81% during 2025-2033. The market is expanding due to surging demand for AI-driven diagnostics, personalized medicine, and efficient healthcare workflows. Growth is fueled by government investments, integration of wearable tech, and rising adoption of predictive analytics, making the industry more dynamic, precise, and competitive

Key Market Highlights:

✔️ Rapid digital transformation across healthcare systems is accelerating AI adoption for diagnostics, treatment planning, and patient monitoring
✔️ Increasing government and private investments are supporting AI-driven medical innovations and research
✔️ Growing integration of machine learning in medical imaging, virtual care, and hospital workflow automation is improving clinical outcomes and operational efficiency

Request for a sample copy of the report https://www.imarcgroup.com/canada-artificial-intelligence-in-healthcare-market/requestsample

Canada Artificial Intelligence in Healthcare Market Trends and Drivers:

The Canada Artificial Intelligence in Healthcare Market is undergoing a dynamic transformation, shaped by progressive regulatory frameworks such as the Artificial Intelligence and Data Act (AIDA). With growing public concern over health data privacy in 2024, Health Canada expedited the approval process for AI diagnostic tools, resulting in a 40% year-over-year increase in AI-assisted imaging solutions. Provincial programs, including Ontario's $120 million AI Health Fund, have spurred partnerships between startups like Deep Genomics and major hospital networks.

Rising demand for AI-powered remote patient monitoring-up 55% post-2024-is being driven by an aging population and persistent physician shortages. However, fragmented interprovincial data-sharing regulations continue to challenge scalability, prompting healthcare organizations to implement hybrid cloud architectures that comply with both PIPEDA and regional mandates. Meanwhile, ongoing ethical concerns about algorithmic bias in Indigenous healthcare are calling for more robust oversight in 2025.

A major contributor to Canada Artificial Intelligence in Healthcare Market Size is precision oncology, which led demand in 2024 with AI-driven genomic tools capturing 32% of the market. National efforts like the Pan-Canadian Genome Library utilize federated learning to analyze over 500,000 patient genomes while maintaining stringent data privacy standards. Pharmaceutical firms, including Roche, invested more than $200 million to leverage AI in drug discovery, focusing on rare diseases that disproportionately affect Canada's diverse population.

Real-world evidence platforms such as BlueDot are increasingly adopted to predict outbreaks like Lyme disease, though data silos between academic and research hospitals continue to limit AI model performance. Rural AI adoption remains uneven, with telehealth usage in remote areas at just 15%, reflecting broader disparities in AI access despite government-led broadband initiatives Surging demand for AI surgical robotics is another key growth driver Breakthroughs in haptic feedback and computer vision during 2024 enabled companies like Montreal-based Corindus to reduce cardiac intervention errors by 60% and shorten patient recovery times by 30%.

AI is also being adopted for healthcare administration-streamlining operations like billing and scheduling, resulting in annual savings of $380 million. Voice-AI tools are now assisting nurses with real-time clinical documentation, improving workflow efficiency. However, rising supply chain costs in 2024 inflated robotics prices, slowing adoption among small and mid-sized enterprises. Cybersecurity threats have intensified, particularly following high-profile attacks on Quebec hospitals, exposing vulnerabilities in AI-driven surgical and IoT systems Compounding this is Canada's ongoing talent drain, with an estimated 75% of AI developers relocating to the U.S., straining domestic innovation capacity.

The Canada Artificial Intelligence in Healthcare Market thrives on strong collaboration among academic institutions, government agencies, and industry stakeholders. Key mid-2020s milestones include Health Canada's fast-tracking of AI radiology tools and Alberta's $90 million investment into AI ethics research. While the market initially focused on diagnostics, there has been a notable shift toward predictive care, with AI models now forecasting ICU bed shortages and chronic disease complications like diabetes.

Despite global chip shortages delaying robotic system rollouts, cloud-based AI adoption surged 48% in 2024 as hospitals prioritized scalable, cost-effective solutions. Harmonization of Canadian regulations with EU and U.S. AI frameworks is unlocking new export opportunities, although data sovereignty and cross-border compliance remain contentious. Looking ahead to 2025, decentralized clinical trials for rare diseases and Indigenous-led data governance initiatives will be central to balancing innovation with equity, driving sustainable expansion in Canada Artificial Intelligence in Healthcare Market Size and influence.

Buy Report Now: https://www.imarcgroup.com/checkout?id=28900&method=1160

Canada Artificial Intelligence in Healthcare Market Segmentation:

The market report segments the market based on product type, distribution channel, and region:

Study Period:

Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033

Breakup by Offering:

• Hardware
• Software
• Services

Breakup by Technology:

• Machine Learning
• Context Aware Computing
• Natural Language Processing
• Others

Breakup by Application:

• Robot-Assisted Surgery
• Virtual Nursing Assistant
• Administrative Workflow Assistance
• Fraud Detection
• Dosage Error Reduction
• Clinical Trial Participant Identifier
• Preliminary Diagnosis
• Others

Breakup by End User:

• Healthcare Providers
• Pharmaceutical and Biotechnology Companies
• Patients
• Others

Breakup by Region:

• Ontario
• Quebec
• Alberta
• British Columbia
• Others

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=28900&flag=C

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

This release was published on openPR.